This case series is the first to demonstrate outcomes from several adolescents and young adults with T1D who are on GLP-1 RAs, providing valuable real-world experience with these medications and highlighting practical issues associated with their use. The gene discussed is GLP1R; the disease is type 1 diabetes mellitus.